Drug intelligence / Profile preview

DuraDerm

Development stage
Unknown
Lead developer
DuraDerm SPORT
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

DuraDerm refers to two distinct medical products: a microbicidal liquid polymer and a cadaveric dermal allograft. The modern DuraDerm (often stylized as DuraDerm®) is an FDA-cleared 510(k) medical device consisting of an organic polymer dissolved in a methylene chloride solvent. Upon topical application, the solvent evaporates to form a clear, flexible, and occlusive elastomeric film that protects wounds from water, dirt, and pathogens while providing immediate microbicidal activity against bacteria, fungi, and viruses. It is indicated for minor wounds, scrapes, and post-operative care, and has been investigated for the reduction of pin track infections in orthopedic surgery. Historically, DuraDerm also referred to a decellularized cadaveric dermal allograft (Bard DuraDerm) used in reconstructive surgeries such as pubovaginal slings, though this product is largely discontinued.

Brand names
DuraDerm
Other names
Bard DuradermDuraDerm allograftmicrobicidal liquid polymer

Beyond the preview

Go deeper on DuraDerm.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DuraDerm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call